Karin Hehenberger, MD, PhD

Dr. Hehenberger has close to 20 years of experience in the life sciences sector.  She served as an executive at Eyetech Pharmaceuticals (EYET) & Coronado BioSciences (CNDO) and had strategic management roles at Johnson & Johnson (Vice President Metabolic Strategy), JDRF (Senior Vice President Strategic Alliances), and McKinsey, as well as senior partnership roles at public (Brummer & Partners) and private (Scandinavian Life Science Ventures) multibillion dollar investment funds.  She received her MD and PhD degrees from the Karolinska institute, and did her post-doctoral fellowship as a JDRF stipend recipient at the Joslin Diabetes Center, Harvard Medical School.